UTHealth Houston Research

January 24, 2025

UTHealth Houston establishes Fetal Institute focused on clinical care, research discovery, and education to advance fetal medicine

Written By: Jeannette Sanchez | Updated: January 24, 2025

Five years after the first groundbreaking fetoscopic spina bifida repair surgery using an innovative patch pioneered by researchers at UTHealth Houston, the fetal medicine team is celebrating the more than 100 procedures performed by the physicians and the launch of the UTHealth Houston Fetal Institute.

January 15, 2025

Link between gene duplications and deletions within chromosome region and nonsyndromic bicuspid aortic valve disease found by UTHealth Houston researchers

Written By: Sydney Lowther | Updated: January 15, 2025

Large and rare duplications and deletions in a chromosome region known as 22q11.2, which involves genes that regulate cardiac development, are linked to nonsyndromic bicuspid aortic valve disease, according to a new study led by UTHealth Houston researchers.

January 13, 2025

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Written By: Deborah Mann Lake | Updated: January 13, 2025

In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage community partners to improve the design of clinical trials.

January 7, 2025

UTHealth Houston study reveals two new genes associated with variants linked to epilepsy, offering new hope for personalized therapies

Written By: Laura Frnka-Davis | Updated: January 7, 2025

New research led by UTHealth Houston scientists uncovered two genes associated with variants linked to epilepsy, which showed specific traits that make them promising diagnostic biomarkers. The study was recently published in Nature Communications.

December 3, 2024

UTHealth Houston study funded by $3.5M NIH grant holds promise for advancing shoulder injury treatments for young athletes

Written By: Laura Frnka-Davis | Updated: December 3, 2024

A new UTHealth Houston study focused on finding the best surgical technique for reconstruction of the acromioclavicular joint (ACJ), where the collarbone meets the shoulder blade, has the potential to enhance recovery and long-term shoulder health for young athletes.

November 25, 2024

At the Bedside: Stem cell therapy through UTHealth Houston clinical trial gives longtime epilepsy patient relief from debilitating seizures

Written By: Jeannette Sanchez | Updated: November 25, 2024

After graduating EMT school in 2014, Luke was fully prepared to take the call to help people and families in need. But one thing he didn’t prepare for was to be the one on the other end of the line asking for help.

October 22, 2024

At-home brain stimulation for depression is safe and effective, according to research from UTHealth Houston, King’s College London, and University of East London

Written By: Deborah Mann Lake | Updated: October 22, 2024

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London.

October 10, 2024

Innovative stem cell trial for bipolar disorder at UTHealth Houston gives patient hope

Written By: Deborah Mann Lake | Updated: October 10, 2024

Ashley Hallock, 35, describes the day she joined a clinical trial studying stem cells for bipolar disorder as the most important day of her life. “For me, it was a godsend,” she said.

October 9, 2024

UTHealth Houston awarded $2.5 million grant to improve outcomes for stroke patients with large blood vessel blockages

Written By: Deborah Mann Lake | Updated: October 9, 2024

Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.

October 7, 2024

First infusion in Houston for new Alzheimer’s drug administered at UTHealth Houston

Written By: Jeannette Sanchez | Updated: October 7, 2024

UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease. The recipient, 79-year-old Terrie Frankel, received the infusion last week.

Find a Doctor/Provider

Select an area

Patient Care

Patient Resources

New Patient?

Billing

Patient Services

1-855-877-2808

Customer Service Hours

Mon – Thu, 8 a.m. to 8 p.m.

Fri, 8 a.m. to 5 p.m.

Sat, 9 a.m. to 1 p.m.

CST time zone

Insurance

More

Alert!

News & Articles